7599 Anagram Drive
Eden Prairie, MN 55344
United States
952 426 1383
https://www.n1mtc.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 16
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. David A. Rosa M.D. | President, CEO & Director | 759,98k | N/A | 1964 |
Mr. Ronald W. McClurg | Chief Financial Officer | 358,79k | N/A | 1960 |
Mr. Steven Mertens | Chief Technology Officer | 332,26k | N/A | 1963 |
Mr. Mark Christianson | Co-Founder, Business Development Director & Medical Sales Liaison | 260,85k | N/A | 1967 |
Mr. Christopher R. Volker CFA | Chief Operating Officer | N/A | N/A | N/A |
Mr. Hijaz Haris | Vice President of Marketing | N/A | N/A | N/A |
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporations ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.